NYSE:GKOSMedical Equipment
What Glaukos (GKOS)'s Strong Q2 Results and Upgraded Guidance Mean For Shareholders
Glaukos Corporation reported strong second quarter 2025 results, with sales rising to US$124.12 million and net loss narrowing to US$19.66 million compared to the same period last year, alongside a raised full-year revenue guidance now projected at US$480–486 million.
This performance highlights Glaukos' improving operational efficiency and management confidence, as reflected in their updated revenue outlook and reduced losses over both the quarter and first half of 2025.
We'll examine how...